CareLit · DOI-Nachweis · Pneumologie
Riociguat for pulmonary hypertension – experience from a referral center
DOI 10.1055/s-0036-1572023
Bibliografische Angaben
Nachweis in CareLit
Autor:innenH Gall, MJ Richter, K Tello, J Grimminger, F Grimminger, W Seeger, A Ghofrani
ZeitschriftPneumologie
Ausgabe02/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Several achievements have been made in the treatment of pulmonary hypertension (PH). Soluble guanylate cyclase (sGC) stimulator Riociguat has been approved for the treatment of pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) and is available in Europe since April 2014. Methods: A one-year prospective data collection of PH patients that started oral targeted…
Zitieren
Zitierempfehlung
H Gall, MJ Richter, K Tello, J Grimminger, F Grimminger, W Seeger, A Ghofrani (2016) Riociguat for pulmonary hypertension – experience from a referral center. Pneumologie (02). https://doi.org/10.1055/s-0036-1572023
Mit CareLit weiterarbeiten